ePS3.10 Patient demographics and baseline disease characteristics in a multicentre, randomised, double-blind, placebo-controlled phase 2b study of lenabasum, a selective cannabinoid receptor type 2 agonist, in cystic fibrosis
| Autor: | Q. Dinh, Raphaël Chiron, N. Dgetluck, James F. Chmiel, Isabelle Fajac, Patrick A. Flume, Natalie E. West, Donald R. VanDevanter, Michael W. Konstan, B. White, Joseph Elborn |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pulmonary and Respiratory Medicine
Agonist medicine.medical_specialty business.industry medicine.drug_class Patient demographics Placebo medicine.disease Cystic fibrosis Gastroenterology Double blind Internal medicine Pediatrics Perinatology and Child Health Cannabinoid receptor type 2 Medicine Disease characteristics business |
| Zdroj: | Journal of Cystic Fibrosis. 19:S45-S46 |
| ISSN: | 1569-1993 |
| DOI: | 10.1016/s1569-1993(20)30310-6 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect